Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 4.58%
March 31, 2026 15.29%
December 31, 2025 24.36%
September 30, 2025 18.71%
June 30, 2025 50.10%
March 31, 2025 53.20%
December 31, 2024 48.56%
September 30, 2024 43.96%
June 30, 2024 38.34%
March 31, 2024 32.34%
December 31, 2023 37.79%
September 30, 2023 44.91%
June 30, 2023 17.09%
March 31, 2023 38.88%
December 31, 2022 -9.26%
September 30, 2022 80.06%
June 30, 2022 -120.8%
March 31, 2022 36.56%
December 31, 2021 89.82%
September 30, 2021 -458.5%
June 30, 2021 17.12%
March 31, 2021 36.89%
December 31, 2020 66.97%
September 30, 2020 -34.55%
June 30, 2020 22.97%
Date Value
March 31, 2020 63.64%
December 31, 2019 61.26%
September 30, 2019 58.97%
June 30, 2019 41.06%
March 31, 2019 62.85%
December 31, 2018 62.63%
September 30, 2018 53.57%
June 30, 2018 56.10%
March 31, 2018 56.79%
December 31, 2017 39.59%
September 30, 2017 53.51%
June 30, 2017 49.18%
March 31, 2017 46.85%
December 31, 2016 42.80%
September 30, 2016 45.17%
June 30, 2016 55.08%
March 31, 2016 38.35%
December 31, 2015 48.29%
September 30, 2015 41.57%
June 30, 2015 27.97%
March 31, 2015 13.60%
December 31, 2014 21.15%
September 30, 2014 25.50%
June 30, 2014 56.12%
March 31, 2014 28.12%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Nicox SA --
DBV Technologies SA --
Cellectis SA 15.62%
Genfit SA --
Innate Pharma SA --

Gross Profit Margin (Quarterly) Related Metrics